AbbVie expands in the medical aesthetics market

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. Meanwhile, the company is also a major player in medical aesthetics—a profitable niche between the beauty industry and plastic surgery.
ABBVIE INC., $115.53, (New York symbol ABBV; TSINetwork… Read More

Two Canadian ETFs hold most of Canada’s best stocks

Two Canadian ETFs hold most of Canada’s best stocks

Today, we look at two Canadian ETFs that hold many of the Canadian stocks we recommend for 2021. iShares S&P/TSX 60 Index ETF and iShares Canada Select Dividend Index ETF mirror, respectively, sub-indexes holding the 60 most-heavily trades stocks and 30 of the highest-yielding dividend stocks… Read More

AbbVie’s diversification pays off

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc.
Over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think… Read More

Get a 5% yield from Abbvie Inc.

Get a 5% yield from Abbvie Inc.

We continue to see attractive investment opportunities for our subscribers in top drug stocks, including this one. We also like spinoffs, which are about as close as you can get to a sure thing in investing.

This company combines both themes and we feel further… Read More